a year ago
Wobble Genomics Raises €9.9 Million to Revolutionize RNA Sequencing
Wobble Genomics, a University of Edinburgh spin-out, has secured €9.9 million in funding to commercialize its novel RNA sequencing technology
The funding round was led by Mercia Ventures and BGF, with participation from IQ Capital, EOS Advisors, and Old College Capital
Wobble Genomics' technology enables the detection of previously invisible 'full length' RNA, which has wide-ranging applications in drug development, research, agriculture, and ecology
The company, founded by Dr
Richard Kuo, plans to use the funding to further develop and commercialize its technology, expanding its team and pursuing its mission to unlock the potential of RNA.
ProblemBiotechnology
"Current RNA sequencing technologies can only measure small fragments of RNA, missing important information, whereas Wobble Genomics' technology enables long-read sequencing, allowing for optimal detection of full-length RNA."
Solution
"Wobble Genomics' technology enables long-read sequencing, allowing for optimal detection of full-length RNA, which can be used in various applications such as drug development, research, agriculture, and ecology, providing a better understanding of cell behavior and reaction to different situations."